検索
検索条件の追加:
検索条件を追加することで検索結果を絞り込むことができます。
検索結果:
| 書誌情報 | ファイル |
|---|---|
| Gelatin sheet incorporating basic fibroblast growth factor enhances healing of the devascularized sternum in diabetic rats. Iwakura, A; Tabata, Y; Doi, K; Nishimura, K; Nakamura, T; Shimizu, Y; Komeda, M (2000) CIRCULATION, 102(18): 465-465 | |
| Novel method to induce therapeutic angiogenesis in limb ischemia with use of basic fibroblast growth factor-incorporating gelatin hydrogel Marui, A; Tabata, Y; Doi, K; Hirose, K; Yamamoto, M; Kushibiki, T; Nishina, T; Ikeda, T; Nishimura, K; Komeda, M (2003) ATHEROSCLEROSIS SUPPLEMENTS, 4(2): 171-171 | |
| Control-release of hepatocyte growth factor (HGF) via gelatin hydrogel sheets improves left ventricular function in a rat model of dilated cardiomyopathy (DCM) Tambara, K; Sakaguchi, G; Sakakibara, Y; Iwai-Kanai, E; Premaratne, GU; Horii, T; Miwa, S; Ozeki, M; Yamamoto, M; Tabata, Y; Komeda, M (2002) CIRCULATION, 106(19): 350-350 | |
| Intravenous infusion of basic fibroblast growth factor prevents monocrotaline-induced pulmonary hypertension in rats Iwakura, A; Fujita, M; Tabata, Y; Ikai, A; Yanazume, T; Komeda, M (2001) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37(2): 270A-270A | |
| Local therapy with control-released basic fibroblast growth factor (bFGF) in the cardiac field Tambara, K; Sakakibara, Y; Sakaguchi, G; Nakajima, H; Premaratne, G; Marui, A; Yamamoto, M; Tabata, Y; Nishimura, K; Komeda, M (2003) ATHEROSCLEROSIS SUPPLEMENTS, 4(2): 63-64 | |
| Prevasculrization using gelatin microsphere containing basic-fibroblast growth factor enhances the benefits of cardiomyocytes transplantation in rats with ischemic cardiomyopathy. Sakakibara, Y; Yamamoto, M; Nishimura, K; Nishina, T; Miwa, S; Handa, N; Nomoto, T; Tanbara, K; Tabata, Y; Komeda, M (2000) CIRCULATION, 102(18): 650-650 | |
| Developing "Bio-CABG" - Revascularizing numerous coronary branches by the arterial graft Ueyama, K; Ozaki, M; Tabata, Y; Doi, K; Nishimura, K; Komeda, M (2002) CIRCULATION, 106(19): 552-552 | |
| Which is a mote effective angiogenetic therapy, bone marrow implantation or control-released basic fibroblast growth factor administration? Sakakibara, Y; Tambara, K; Sakaguchi, G; Li, FL; Premaratne, GU; Lin, X; Yamamoto, M; Tabata, Y; Nishimura, K; Komeda, M (2002) CIRCULATION, 106(19): 419-419 | |
| Therapeutic angiogenesis: Growth factor approach is more effective and practical Komeda, M; Sakakibara, Y; Tambara, K; Sakaguchi, G; Premaratne, GU; Lin, X; Yamamoto, M; Tabata, Y; Nishimura, K (2003) ATHEROSCLEROSIS SUPPLEMENTS, 4(2): 95-95 | |
| A new method of preventing catheter-related MRSA infection by angiogenesis effects of control-released bFGF Hirose, K; Marui, A; Arai, Y; Nomura, T; Ozeki, M; Inoue, S; Huang, YH; Dol, K; Mitsuyama, M; Tabata, Y; Komeda, M (2004) CIRCULATION, 110(17): 596-596 |